1. P60 Effect of Indacaterol/Glycopyrronium (IND/GLY) on patient-reported outcomes in men and women with COPD: a pooled analysis from the ignite programme. (15th November 2016) Authors: Kostikas, K; Tsiligianni, I; Fucile, S; Mezzi, K; Shen, S; Banerji, D; Fogel, R Journal: Thorax Issue: Volume 71(2016)Supplement 3 Page Start: A116 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. S117 Poor adherence in exacerbating COPD patients: magnitude and related factors at baseline in the MAGNIFY pragmatic trial. (11th November 2022) Authors: Dickens, AP; Halpin, DMG; Carter, V; Skinner, D; Beeh, K; Chalmers, J; Clark, A; Hannan, N; Kaplan, A; Kostikas, K; Pinnock, H; Roche, N; Usmani, O; van Boven, JFM; Mastoridis, P; Mezzi, K; Davis, S; Vijaykumar, E; Price, D Journal: Thorax Issue: Volume 77(2022)Supplement 1 Page Start: A72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P186 Facilitators to recruiting COPD patients to an adherence intervention trial. (11th November 2022) Authors: Dickens, AP; Halpin, DMG; Carter, V; Skinner, D; Beeh, K; Chalmers, J; Clark, A; Hannan, N; Kaplan, A; Kostikas, K; Pinnock, H; Roche, N; Usmani, O; van Boven, JFM; Mastoridis, P; Mezzi, K; Davis, S; Vijaykumar, E; Price, D Journal: Thorax Issue: Volume 77(2022)Supplement 1 Page Start: A182 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P235 Dual-bronchodilation with once-daily QVA149 in patients with moderate-to-severe COPD: overview of the IGNITE program. (14th November 2013) Authors: Price, D; Mezzi, K; Fedele, MJ; Chen, H; Banerji, D Journal: Thorax Issue: Volume 68(2013)Supplement 3 Page Start: A183 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗